Acknowledgement
We thank Dr. Brandon Greene (Institute of Medical Biometry and Epidemiology, Philipps University Marburg, Germany) for his support with the statistical analyses.
References
- Fatemi HM. The luteal phase after 3 decades of IVF: what do we know? Reprod Biomed Online 2009;19 Suppl 4:4331. https://doi.org/10.1016/S1472-6483(10)61065-6
- Yanushpolsky EH. Luteal phase support in in vitro fertilization. Semin Reprod Med 2015;33:118-27. https://doi.org/10.1055/s-0035-1545363
- van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev 2011;(10):CD009154.
- Schwartz E, Bernard L, Ohl J, Bettahar K, Rongieres C, Lichtblau I, et al. Luteal phase progesterone supplementation following induced natural cycle frozen embryo transfer: a retrospective cohort study. J Gynecol Obstet Hum Reprod 2019;48:95-8. https://doi.org/10.1016/j.jogoh.2018.10.011
- Doblinger J, Cometti B, Trevisan S, Griesinger G. Subcutaneous progesterone is effective and safe for luteal phase support in IVF: an individual patient data meta-analysis of the phase III trials. PLoS One 2016;11:e0151388. https://doi.org/10.1371/journal.pone.0151388
- de Ziegler D, Sator M, Binelli D, Leuratti C, Cometti B, Bourgain C, et al. A randomized trial comparing the endometrial effects of daily subcutaneous administration of 25 mg and 50 mg progesterone in aqueous preparation. Fertil Steril 2013;100:860-6. https://doi.org/10.1016/j.fertnstert.2013.05.029
- Venturella R, Vaiarelli A, Buffo L, D'alessandro P, Colamaria S, Pedri S, et al. Progesterone for preparation of the endometrium for frozen-thawed blastocyst transfer in vitro fertilization cycles: a prospective study on patients' opinions on a new subcutaneous formulation. Gynecol Endocrinol 2018;34:766-71. https://doi.org/10.1080/09513590.2018.1451508
- Check JH. Luteal phase support in assisted reproductive technology treatment: focus on Endometrin(R) (progesterone) vaginal insert. Ther Clin Risk Manag 2009;5:403-7. https://doi.org/10.2147/TCRM.S4192
- Vaisbuch E, Leong M, Shoham Z. Progesterone support in IVF: is evidence-based medicine translated to clinical practice? A worldwide web-based survey. Reprod Biomed Online 2012;25:139-45. https://doi.org/10.1016/j.rbmo.2012.04.005
- Penzias AS. Luteal phase support. Fertil Steril 2002;77:318-23. https://doi.org/10.1016/S0015-0282(01)02961-2
- Lockwood G, Griesinger G, Cometti B; 13 European Centers. Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study. Fertil Steril 2014;101:112-9.e3. https://doi.org/10.1016/j.fertnstert.2013.09.010
- Baker VL, Jones CA, Doody K, Foulk R, Yee B, Adamson GD, et al. A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization. Hum Reprod 2014;29:2212-20. https://doi.org/10.1093/humrep/deu194
- Child T, Leonard SA, Evans JS, Lass A. Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles. Reprod Biomed Online 2018;36:630-45. https://doi.org/10.1016/j.rbmo.2018.02.001
- Supramaniam PR, Mittal M, McVeigh E, Lim LN. The correlation between raised body mass index and assisted reproductive treatment outcomes: a systematic review and meta-analysis of the evidence. Reprod Health 2018;15:34. https://doi.org/10.1186/s12978-018-0481-z
- Yavuz A, Demirci O, Sozen H, Uludogan M. Predictive factors influencing pregnancy rates after intrauterine insemination. Iran J Reprod Med 2013;11:227-34.
- Gaskins AJ, Toth TL, Chavarro JE. Prepregnancy nutrition and early pregnancy outcomes. Curr Nutr Rep 2015;4:265-72. https://doi.org/10.1007/s13668-015-0127-5
- van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev 2015;2015:CD009154.